Pulse Co-oximeter

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

Compra'l ara

Disponible des:

Masimo Australia Pty Ltd

clase:

Class IIb

Fabricat per:

Masimo Corporation 52 Discovery, Irvine, CA, 92618 United States Of America

Área terapéutica:

46201 - Pulse Co-oximeter

indicaciones terapéuticas:

The device is indicated for the continuous non-invasive monitoring of functional oxygen saturation of arterial haemoglobin (SpO2), pulse rate, carboxyhemoglobin saturation, methemoglobin saturation, total haemoglobin concentration, and/or respiratory rate.; and is indicated for use with adult, paediatric, and neonatal patients during both no motion and motion conditions, and for patients who are well or poorly perfused in hospitals, hospital-type facilities, and mobile environments. The device has an additional mode to provide clinicians with a guided tool to help screen newborns for Critical Congenital Heart Disease (CCHD) per the established CCHD Screening protocol.

Estat d'Autorització:

A

Data d'autorització:

2008-12-03

Cerqueu alertes relacionades amb aquest producte

Veure l'historial de documents